Alternative medicine uses chelation therapy as a non-standard treatment for some ailments, including heart disease and autism.[14][15] In 2010 the U.S. Food and Drug Administration (FDA) warned companies who sold over-the-counter (OTC) chelation products and stated that such "products are unapproved drugs and devices and that it is a violation of federal law to make unproven claims about these products. There are no FDA-approved OTC chelation products."[4]
Attempts have been made to use it in treating kidney dysfunction, calcific band keratopathy (an eye disorder), and ovarian cancer. The U.S. National Center for Complementary and Alternative Medicine (NCCAM) conducted a trial on the chelation therapy's safety and efficacy for patients with coronary artery disease.[16] NCCAM Director Stephen E. Straus cited the "widespread use of chelation therapy in lieu of established therapies, the lack of adequate prior research to verify its safety and effectiveness, and the overall impact of coronary artery disease" as factors motivating the trial.[17] The proposed study has been criticized as unethical, unnecessary and dangerous, with multiple studies conducted in the past demonstrating that it provides no benefits.[2]
Cancer
The American Cancer Society says of chelation therapy: "Available scientific evidence does not support claims that it is effective for treating other conditions such as cancer. Chelation therapy can be toxic and has the potential to cause kidney damage, irregular heartbeat, and even death."[3]
Heart disease
The use of EDTA chelation therapy as a treatment for coronary artery disease has not been shown to be effective and is not approved by the U.S. Food and Drug Administration (FDA).[18] Several possible mechanisms have been proposed, though none have been scientifically validated. The US National Center for Complementary and Alternative Medicine began conducting the Trial to Assess Chelation Therapy (TACT) in 2003.[16] Patient enrollment was to be completed around July 2009[7] with final completion around July 2010,[16] but enrollment in the trial was suspended on September 26, 2008 for an investigation by OHRP after complaints about ethical concerns such as inadequate informed consent.[19] The trial has been criticized for lacking prior Phase I and II studies, and particularly because previous controlled trials have not indicated benefits.[2] The American College for Advancement in Medicine, a controversial organization created to promote chelation therapy, has played a part in the adoption of the TACT clinical trial, which has led to further criticism of the trial.[2] Atwood et al. have argued that methodological flaws and lack of prior probability make this trial "unethical, dangerous, pointless, and wasteful."[2]
The final results of TACT, published in November 2012, showed no support for the use of chelation therapy in coronary heart disease, particularly the claims to reduce the need for coronary artery bypass grafting.[20][21][22]
The American Heart Association states that there is "no scientific evidence to demonstrate any benefit from this form of therapy" and that the "United States Food and Drug Administration (FDA), the National Institutes of Health (NIH) and the American College of Cardiology all agree with the American Heart Association" that "there have been no adequate, controlled, published scientific studies using currently approved scientific methodology to support this therapy for cardiovascular disease."[18] Like other scientific commentators, they note that any improvement among heart patients undergoing chelation therapy can be attributed to the placebo effect and lifestyle changes discovered in conventional medicine but recommended by chelationists; "quitting smoking, losing weight, eating more fruits and vegetables, avoiding foods high in saturated fats and exercising regularly". They note their concern that patients could put off proven treatments for heart disease like drugs or surgery. A
Shabbir Taherali Dadabhai
Cellphone no +254723024308 Sent from my BlackBerry®
Cellphone no +254723024308 Sent from my BlackBerry®
From: Mohamed Jaffer <mjkassam@gmail.com>
Sender: keep_mailing@googlegroups.com
Date: Fri, 18 Apr 2014 12:12:48 +0100
To: HEART<Have-A-Heart@yahoogroups.com>; <keep_mailing@googlegroups.com>
ReplyTo: mjkassam@gmail.com
Subject: [ ::: ♥Keep_Mailing♥ ::: ]™ HOW TO AVOID ANGIOGRAPHY
Recently, one person was admitted to a nursing home
at Kandivili, Mumbai due to severe chest pain. He had an earlier attack in 1997 and was under treatment. The doctors now suggested Angiography. Upon undergoing Angiography at Hinduja Hospital - Doctors diagnosed multiple blockages for which Angioplasty was ruled out and instead, suggested 'Bypass Surgery'.
That evening, he was brought home as doctor suggested his heart being very weak, bypass can be performed only after 15 - 20 days.
Meanwhile, whilst discussing the matter with relatives and close friends, fresh information came from a family friend.
A new treatment known as - Chelation Therapy has been introduced into the Indian medical theatre.
With this therapy, a patient who has to undergo by-pass need not do so.
Instead, the patient is given about 18 bottles of blood in which certain medicaments are injected. The blood cleans the system and removes all blockages from the heart and arteries. The number of bottles given may increase depending upon the age-factor and health of patient.
Cost per bottle may be around Rs.2,500/- Treatment takes about a month.
Currently, only a few doctors in India specialise in this field
One of them is Dr. Dhananjay Shah at Malad (Mumbai).
He has a list of patients who had to undergo by-pass from Lilavati, Hinduja and other major hospitals; but, instead after undergoing the new treatment, they are absolutely fine and are leading a normal life.
Doctor's details for your info are:
Dr. Dhananjay Shah Hospital
Tel:
022-28892089
Mob: 98194 39657
Email: shahdhananjay@rediffmail.com
Dr. Hiten Shah
Integrative Cardiac-Vascular Clinic Heart Rehab
Centre, 230, Satyam Mall,
Ashirwad Poly Clinic,
Ahmedabad,
GJ 380015
Tel: +91 09998848590
or
9898077966
Fax: 07940067882.
Please forward this message It Might Help Someone
Medicine for Blood Cancer has been found!!!! Please,
don't delete this without forwarding.
I am forwarding it to the maximum I can.
Let it reach the 110 crores Indians and the remaining if
any.
'Imitinef Mercilet' is a medicine which cures blood
cancer.
Its available free of cost at
"Adyar Cancer
Institute in Chennai". Create Awareness.
It might help someone.Forward to as many as u can,
Kindness costs nothing.
Cancer Institute in Adyar, Chennai.
Category:Cancer
Address:East Canal Bank Road ,
Gandhi Nagar,Adyar,Chennai -600020 Landmark: Near Michael School
Phone:
044-24910754
044-24910754 ,
044-24911526 044
Request:
Forward as maximum as you can. May God reward u.
VERY IMPORTANT INFORMATION IS PROVIDED BY OUR GOOD FRIEND....I REQUEST ALL READERS TO SPREAD THIS MESSAGE TO MAXIMUM PEOPLE....
IT WILL HELP TO SURVIVE SOMEBODY FROM THE DISEASES & GOD WILL GRACE YOU FOR THE SAME......
You received this message because you are subscribed to the Google Groups "Keep_Mailing" group.
To unsubscribe from this group and stop receiving emails from it, send an email to keep_mailing+unsubscribe@googlegroups.com.
To post to this group, send email to keep_mailing@googlegroups.com.
For more options, visit https://groups.google.com/d/optout.
No comments:
Post a Comment